Corrigendum: "Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments" [BIOPHA 176 (2024) 116808] - 19/07/26

Mohsen Nabi-Afjadi ^{a, ⁎} , Samane Ostadhadi ^b, Mahsa Liaghat ^{c, d}, Ajay Prakash Pasupulla ^e, Sajjad Masoumi ^f, Fatemeh Aziziyan ^{a, d}, Hamidreza Zalpoor ^{d, g}, Leila Abkhooie ^{h, i}, Vahideh Tarhriz ^{j, ⁎}

^a Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran 

^b Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran 

^c Department of Medical Laboratory Sciences, Faculty of Medical Sciences, Islamic Azad University, Kazerun Branch, Kazerun, Iran 

^d Network of Immunity in Infection, Malignancy & Autoimmunity (NIIMA), Universal Scientific Education & Research Network (USERN), Tehran, Iran 

^e Oral and Maxillofacial Pathology, School of Medicine, Colllege of health Sciences, Wachemo University, Hosanna, Ethiopia 

^f Department of Medical Biotechnology, National institute of Genetic Engineering and Biotechnology, Tehran, Iran 

^g Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 

^h Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran 

ⁱ Department of Medical Biotechnology, School of Medicine,Lorestan University of Medical Sciences, Khorramabad, Iran 

^j Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA 

^⁎ Corresponding authors.

Le texte complet de cet article est disponible en PDF.